CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,170,000 | +24.9% | 250,804 | -3.0% | 0.07% | -1.4% |
| Q3 2020 | $2,539,000 | -3.3% | 258,533 | -2.1% | 0.07% | -3.9% |
| Q2 2020 | $2,626,000 | +14.1% | 263,958 | +1.4% | 0.08% | -10.6% |
| Q1 2020 | $2,302,000 | +163.4% | 260,362 | +174.9% | 0.08% | +304.8% |
| Q4 2019 | $874,000 | +54.1% | 94,697 | -1.7% | 0.02% | +50.0% |
| Q3 2019 | $567,000 | -52.3% | 96,377 | -2.8% | 0.01% | -50.0% |
| Q2 2019 | $1,189,000 | – | 99,106 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |